Overview
Status
Active
Registry date
2002-07-05
Share capital
50,400.00 PLN
Registered address
ul. Krupnicza 8/3a, 31-123 Kraków, Poland
Financials
Only balance sheet data (assets and liabilities) is available. The income statement (P&L) is not available in the source filing for this period.
Revenue history
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 3 of 6 financial statements were filed late (the longest delay 378 days for 2019).
- 2025not filed
- 202406/06/2025
- 202304/07/2024
- 202230/03/2023
- 202129/03/2023
- 202028/10/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Stanisław Pabian – President of the Management Board
Manner of representation
The management board of the company consists of between one and five persons. In the case of a multi-member management board, two members of the management board acting jointly are authorised to make declarations of will on behalf of the company and to represent the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Stanisław Pabianage 66 | 63 | $11,912.48 | 87.5% |
Beata Pabian Mikułaage 42 | 9 | $1,701.78 | 12.5% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 1999-05-10.
20 1090 1665 0000 0001 6548 5928
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Aflofarm Farmacja Polskasp. z o.o. | $302,019,142.07 | aflofarm.pl | ||
| Przedsiębiorstwo Produkcji Farmaceutycznej Hasco - LekS.A. | $119,621,017.71 | hasco-lek.pl | ||
| PolfarmexS.A. | $73,543,379.32 | polfarmex.pl | ||
| Celon PharmaS.A. | $52,550,739.16 | celonpharma.com | ||
| Instytut Biotechnologii Surowic i Szczepionek Biomed - Skrót Firmy Ibss BiomedS.A. | $37,103,878.54 | biomed.pl | ||
| Curtis Health CapsS.A. | $30,831,117.38 | chc.com.pl | ||
| Fagronsp. z o.o. | $21,715,187.73 | fagron.pl | ||
| Krakowskie Zakłady Zielarskie Herbapol w KrakowieS.A. | $7,294,338.51 | herbapol.krakow.pl | ||
| F1 PharmaS.A. | $272,113.66 | f1pharma.pl | ||
| Zakład Farmaceutyczny Amarasp. j. | $0.00 | amara.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-05-25 | Business resumed | |
| 2018-08-01 | Business suspended | |
| 2009-02-27 | Name change (Astra - Logos Express → "nel - Dystrybucja") | |
| 2006-12-27 | Name change (Astra Logos Express → Astra - Logos Express) | |
| 2006-10-11 | Address change (Wodna 3, 30-556, Kraków → Zakopiańska 72, 30-418, Kraków) |
FAQ
The main business activity of NEL - Dystrybucja focuses on manufacture of pharmaceutical preparations.
The company was registered in the Polish National Court Register (KRS) on July 5, 2002.
The headquarters is located at: ul. Krupnicza 8, 31-123 Kraków.
The management board consists of: Stanisław Pabian (President of the Management Board).
The share capital of the company is PLN 50,400 (approx. $13,614).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
Last updated: 2026-04-05